RT Journal
A1 Lens M
T1 DO β-blockers slow down melanoma progression?
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2011
FD October 10
VO 171
IS 18
SP 1686
OP 1687
DO 10.1001/archinternmed.2011.483
UL http://dx.doi.org/10.1001/archinternmed.2011.483
AB 
Although De Giorgi et al1 were the first to report association between β-blockers and tumor progression in patients with melanoma, limited evidence suggests that β-blocker therapy may reduce tumor recurrence in other malignant diseases.2